疫苗的好消息来了
- 主题发起人 caap2012
- 开始时间
Serum Institute to start manufacturing Oxford University's...
www.deccanherald.com/science-and-environment/serum...
2020-04-26 · Vaccine major Serum Institute of India on Sunday said it plans to start production of the COVID-19 vaccine developed by Oxford University in the next two to three weeks and hopes to bring it to the...
Sudhir Suryawanshi
Express News Service
Adar Poonawalla, CEO of Serum Institute of India, which is in an advanced stage of manufacturing a vaccine for COVID-19 in partnership with Oxford University, which is undergoing human trial, tells Sudhir Suryawanshi that production is being started so that the vaccine is already available for use as soon as the trials are successful. Excerpts from the interview:
How much time will it take for the COVID-19 vaccine to be ready and how effective will it be?
We have been working closely with Dr Adrian Hill from Oxford University on the vaccine development. While the clinical trials have already commenced in the UK, we are initiating production as well hoping that when the trials are successful, we will have the first batch of doses ready for use by September or October.
What will be the cost of the one vaccine for people and how many vaccines will be available or produced in a month?
It’s too early to comment on the pricing at this point, but we will surely keep it affordable. We aim to manufacture 4-5 million doses per month, following which we aim to scale up production to 10 million doses a month, based on the success of the trials.
We are looking forward to manufacturing up to 20-40 million doses by September-October. If the trials are successful, we will make the product available in as many countries as possible, including India.
Is Maharashtra or the Central govt helping and playing any role in producing this vaccine?
Yes, we have got full support from the governments and they are looking into it quite proactively.
Are you also making COVID-19 testing kits to scale-up testing for coronavirus?
We have recently partnered with Mylab and will be ramping up the production of COVID-19 testing kits, taking it from 1.5 lakh units per week to 20 lakh units per week. Additionally, we are amplifying our efforts to develop an efficacious vaccine while also strengthening our robust infrastructure to manufacture the same in large quantities. To reduce dependency on imported products to manufacture testing kits in association with Mylabs, we have additionally partnered with Syngene International for the purpose.
Express News Service
Adar Poonawalla, CEO of Serum Institute of India, which is in an advanced stage of manufacturing a vaccine for COVID-19 in partnership with Oxford University, which is undergoing human trial, tells Sudhir Suryawanshi that production is being started so that the vaccine is already available for use as soon as the trials are successful. Excerpts from the interview:
How much time will it take for the COVID-19 vaccine to be ready and how effective will it be?
We have been working closely with Dr Adrian Hill from Oxford University on the vaccine development. While the clinical trials have already commenced in the UK, we are initiating production as well hoping that when the trials are successful, we will have the first batch of doses ready for use by September or October.
What will be the cost of the one vaccine for people and how many vaccines will be available or produced in a month?
It’s too early to comment on the pricing at this point, but we will surely keep it affordable. We aim to manufacture 4-5 million doses per month, following which we aim to scale up production to 10 million doses a month, based on the success of the trials.
We are looking forward to manufacturing up to 20-40 million doses by September-October. If the trials are successful, we will make the product available in as many countries as possible, including India.
Is Maharashtra or the Central govt helping and playing any role in producing this vaccine?
Yes, we have got full support from the governments and they are looking into it quite proactively.
Are you also making COVID-19 testing kits to scale-up testing for coronavirus?
We have recently partnered with Mylab and will be ramping up the production of COVID-19 testing kits, taking it from 1.5 lakh units per week to 20 lakh units per week. Additionally, we are amplifying our efforts to develop an efficacious vaccine while also strengthening our robust infrastructure to manufacture the same in large quantities. To reduce dependency on imported products to manufacture testing kits in association with Mylabs, we have additionally partnered with Syngene International for the purpose.
COVID-19 vaccine may never be found, warns British PM Boris Johnson
As part of global efforts, he flagged the GBP 388 million in aid funding for research into vaccines, tests and treatment, including GBP 250m.
LONDON: British Prime Minister Boris Johnson has warned that a mass vaccine for the novel coronavirus may be over a year away and, in the worst-case scenario, may in fact never be found.
In his foreword to the government's new 50-page guidance on a step by step easing of the lockdown measures in place to control the spread of the deadly virus, the UK prime minister lays out plans for businesses to gradually start reopening with "COVID-19 Secure" measures of social distancing and for the public to use "good solid British common sense" as the economy is unlocked.
"A mass vaccine or treatment may be more than a year away," said Johnson, highlighting the work being done in the UK by scientists at Oxford University and Imperial College London towards this mission.
As part of global efforts, he flagged the GBP 388 million in aid funding for research into vaccines, tests and treatment, including GBP 250m.
LONDON: British Prime Minister Boris Johnson has warned that a mass vaccine for the novel coronavirus may be over a year away and, in the worst-case scenario, may in fact never be found.
In his foreword to the government's new 50-page guidance on a step by step easing of the lockdown measures in place to control the spread of the deadly virus, the UK prime minister lays out plans for businesses to gradually start reopening with "COVID-19 Secure" measures of social distancing and for the public to use "good solid British common sense" as the economy is unlocked.
"A mass vaccine or treatment may be more than a year away," said Johnson, highlighting the work being done in the UK by scientists at Oxford University and Imperial College London towards this mission.
